Get started
BIONTECH SEBIONTECH SEBIONTECH SE

BIONTECH SE

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

BNTX/N trade ideas

Long Thesis on BioNTech SE Post-EarningsBioNTech SE presents a compelling long opportunity following its latest earnings report. The company continues to expand beyond COVID-19 vaccines, with a strong pipeline in personalized mRNA cancer therapies, infectious disease vaccines (HIV, tuberculosis, malaria), and autoimmunity treatments. With €17 billion in cash reserves, minimal debt, and high gross margins (~77%), BioNTech remains financially resilient. Key catalysts for a bullish scenario include: ✅ Successful clinical trials in oncology with accelerated regulatory approvals. ✅ Expansion of BioNTainer production units, enabling decentralized vaccine manufacturing. ✅ New strategic partnerships in the biotech and pharma sector. ✅ Increased demand for mRNA-based flu and variant-specific COVID-19 vaccines. With analysts setting a fair value target of ~$150, the stock's current price (~$100) offers a 33% upside potential. A post-earnings rally towards 130–150 USD is plausible if BioNTech demonstrates strong progress in its oncology segment and secures additional licensing deals.
NASDAQ:BNTXLong
by rencus30
BioNtech SE(Extended Hours) | Chart & Forecast SummaryKey Indicators On Trade Set Up In General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Notes On Session # BioNtech SE(Extended Hours) - Double Formation * Neckline At 88.00 | Double Bottom Confirmation | Subdivision 1 * Support=0 | Failed Target | No Trade - Triple Formation * WXY Wave | Range Structure | Subdivision 2 * Retracement | 0.5 & 0.382 * Trade Execution | Alignment(Short) | Subdivision 3 Active Sessions On Relevant Range & Elemented Probabilities; London(Upwards) - NYC(Downwards) Conclusion | Trade Plan Execution & Risk Management On Demand; Overall Consensus | Buy
CAPITALCOM:BNTXLong
by TradePolitics
BioNtech SE (Extended Hours) | Chart & Forecast SummaryKey Indicators On Trade Set Up In General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Notes On Session # BioNtech SE (Extended Hours) - Triple Formation * Inverted Head & Shoulders | Subdivision 1 * 012345 | Failed Attempt | No Trade! * Triangle Structure | Bearish Continuation | Subdivision 2 - Double Formation * Retracement | 0.5 | Uptrend Bias * Second Shoulder | Subdivision 3 Active Sessions On Relevant Range & Elemented Probabilities; London(Upwards) - NYC(Downwards) Conclusion | Trade Plan Execution & Risk Management On Demand; Overall Consensus | Buy
CAPITALCOM:BNTXLong
by TradePolitics
BNTX’s Next ChapterBioNTech is building strong bullish momentum, with a gap forming around the $93.00 level. A breakout above the $125.83 resistance would confirm further upward movement, positioning the stock to target the $172.41 gap-fill resistance. This trade offers an attractive risk-to-reward ratio, with a stop-loss set at $90.00 to effectively manage downside risk. BioNTech’s continued advancements in mRNA technology, along with its expanding pipeline of vaccines and immunotherapies, bolster its long-term growth potential. As the company diversifies beyond COVID-19 vaccines into oncology and infectious diseases, it remains a leader in the biotechnology sector. Increasing partnerships and new product developments further support BioNTech’s upward trajectory. With a combination of technical momentum and robust fundamentals, BNTX is well-positioned to reach $172.41, making it an appealing opportunity for investors and traders alike. NASDAQ:BNTX
NASDAQ:BNTXLong
by The_Trading_Mechanic
Target still on Both MRNA and BNTX reversed on Friday Engulfing day with decent volume ( and shorts squeeze). The selling was based on playing with the PFE news which effectively was a real no news ( no change in guidance 23 and 24 nobody knows ). In the meantime wastewater traces and hospitalisations for respiratory issues are on the rise worldwide. Cancer vaccines are moving fast ahead. As for 23 my best guess is that both MRNA and BNTX will meet their guidance. So all in all COVID vaccines market will be around USD 18 bil this year.
NASDAQ:BNTXLong
by model421
BioNTech prepping for major upside to 138Inv Head and Shoulders seems to be forming on BioNTech company listed on the Nasdaq. We might have a consolidation period for the final shoulder to form before it breaks up and out of it. There is also a solid uptrend, which the price continues to make higher lows. With the price staying above the 200MA will help the bullish momentum send it to the first target of $138.36. Let's see how it plays out as it's still a bit early before jumping in.
NASDAQ:BNTXLong
by Timonrosso
BNTX Flexibilty during a transitional period.Following last ER, I was impressed by BNTX capacity to flex its costs i.e business model (notably vs MRNA) to keep being profitable. Now 17 Bil. in cash. Also believe it was conservative on its modified 2023 guidance compared with PFE ( one is wrong imo). So i believe it is still a cheap stock trading around 30 net of cash (back to before Covid). It filled the small gap (orange box). I expect it to test 125 again. Then it will be up to the cancer treatment narrative.
NASDAQ:BNTXLong
by model421
BionTech Fastly Approaching Major Resistance, Will we Break?Hi Guys, this is a Technical Analysis on BionTech (BNTX) on the 3 Day Timeframe. We are currently approaching a MAJOR RESISTANCE Trendline. This Trend started from the TOP in 08/2021. Everytime we've interacted with it in the past, we've been REJECTED. Will we get Rejected again? Well, we've had 3 touch points already. In trendline theory, it states that atleast 3 touches are required before a trendline is weak enough to break through. So, it is possible that a break can occur. With risk of new variants, hospitalizations of COVID increasing and a push of government to get people to get boosters, this could be a chance for Trend change to UPSIDE for BNTX. BUT just looking at it in a pure TA lens, i wouldn't just start buying now. I would wait for a break above the Trendline and CONFIRMATION above it. Also with the break, note that VOLUME should be spiking and increasing. We should not see a DECLINE in Volume as we break through. That can be signs of a FAKEOUT. We are also reaching some Resistance from a Support line turned Resistance line. Now lets look at our indicators for more evidence. RSI -> We've had the Lowest RSI reading on May 09,2023 EVER in BNTX history. This could be a catalyst for more buying pressure and a trend change. We also broke above RSI Red Resistance line. MACD-> A momentum indicator, has crossed BULLISH, below the 0 level. If we continue this bullish momentum and the Blue/Orange lines move above the 0 level, this can be inject the well needed momentum for BNTX to increase in price. STOCH RSI -> Is also in a BUllish cross and it shows that theres plenty of room for momentum to continue. __________________________________________________________________________________ Thank you for taking the time to read my analysis. Hope it helped keep you informed. Please do support my ideas by boosting, following me and commenting. Thanks again. Stay tuned for more updates on BNTX in the near future. If you have any questions, do reach out. Thank you again. DISCLAIMER: This is not financial advice, i am not a financial advisor. The thoughts expressed in the posts are my opinion and for educational purposes. Do not use my ideas for the basis of your trading strategy, make sure to work out your own strategy and when trading always spend majority of your time on risk management strategy.
NASDAQ:BNTX
by SafofAllTrades
2